CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 76 enrolled
Drug / intervention
Ventana Fenestrated Stent Graft Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01491945
NCT01491945N/ACompleted

Prospective, Multicenter, Single Arm Safety and Effectiveness Trial of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms

Endologix·interventional·Posted Dec 14, 2011·Updated Oct 15, 2021

In Brief

A clinical study evaluating Ventana Fenestrated Stent Graft System for Abdominal Aortic Aneurysm. Completed, enrolled 76 participants across 22 sites.

Detailed Summary

The purpose of this trial is to determine if the Ventana Fenestrated Stent Graft System is safe and effective for the endovascular repair of juxtarenal or pararenal aortic aneurysms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedDec 14, 2011
Enrollment StartMar 3, 2013
Primary CompletionApr 1, 2017
Study CompletionAug 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 14.5 years ago

Interventions

Ventana Fenestrated Stent Graft Systemdevice

The Ventana Fenestrated Stent Graft System consists of the following: bifurcated stent graft, Ventana fenestrated proximal extension stent graft, and Xpand renal stent grafts